| A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine (NCT07753265) | Changchun BCHT Biotechnology Co. | 2026-08-13 |
| A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) (NCT07633197) | Changchun BCHT Biotechnology Co. | 2026-05-28 |
| A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) (NCT07492303) | Changchun BCHT Biotechnology Co. | 2026-04-20 |
| A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza Vaccine (NCT07545564) | Changchun BCHT Biotechnology Co. | 2026-04-09 |
| A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant) (NCT07349017) | Changchun BCHT Biotechnology Co. | 2026-02-07 |
| A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination (NCT07330440) | Changchun BCHT Biotechnology Co. | 2025-10-13 |
| A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell) (NCT07338786) | Changchun BCHT Biotechnology Co. | 2025-09-13 |
| Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination (NCT07133802) | Changchun BCHT Biotechnology Co. | 2025-08-01 |
| Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial (NCT07112144) | Changchun BCHT Biotechnology Co. | 2025-06-13 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and Older (NCT06961721) | Changchun BCHT Biotechnology Co. | 2025-05-01 |
| Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials (NCT06548139) | Changchun BCHT Biotechnology Co. | 2024-07-31 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation (NCT06360250) | Changchun BCHT Biotechnology Co. | 2024-04-10 |
| Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine (NCT06280144) | Changchun BCHT Biotechnology Co. | 2023-09-22 |
| Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1 (NCT05832073) | Changchun BCHT Biotechnology Co. | 2023-04-30 |
| The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine (NCT05284851) | Changchun BCHT Biotechnology Co. | 2022-04-01 |
| To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants (NCT05189548) | Changchun BCHT Biotechnology Co. | 2021-12-10 |
| The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine (NCT05056519) | Changchun BCHT Biotechnology Co. | 2021-09-20 |
| To Explore a Bridging Index for the Effectiveness of the Clinical Trial (NCT04825340) | Changchun BCHT Biotechnology Co. | 2021-04-16 |
| Study on Efficacy of Attenuated Zoster Vaccine, Live (NCT04334577) | Changchun BCHT Biotechnology Co. | 2020-04-20 |